-
-
In the past half century, technology, environmental awareness, and modern science have surged. Yet, as in all generations, a significant number of consumers, perhaps intent upon getting back to simpler times, are choosing "healthful" therapies not fully accepted by the mainstream.
-
-
NSAIDs in the elderly; managing GI and CVD risk with NSAIDs; low-dose naltrexone and fibromyalgia; treating glucocorticoid-induced bone loss; FDA Actions.
-
-
Aspirin dose and cardioprotection; uncovering modafinil's abuse potential; proton-pump inhibitors and clopidogrel; FDA actions.
-
The need for participation of the primary care physician in the treatment of sleep apnea has become much more apparent in recent years.
-
In light of an increasing internationally mobile community, the primary care physician may see patients who have recently traveled overseas. This article highlights the manifestations of diseases that, although we may not see them often, can fool us with confusing symptoms.
-
-
Individualization of therapy with pharmacogenetics; the rate vs rhythm debate; the FDA's Risk Evaluation and Mitigation Strategy; FDA actions.
